Ford A - Search Results

1

Depression Outcomes Among Patients Treated With Fluoxetine for Stroke Recovery: The AFFINITY Randomized Clinical Trial.

Almeida OP, Hankey GJ, Ford A, Etherton-Beer C, Flicker L, Hackett M; Assessment of Fluoxetine in Stroke Recovery (AFFINITY) Trial Collaboration. Almeida OP, et al. Among authors: ford a. JAMA Neurol. 2021 Sep 1;78(9):1072-1079. doi: 10.1001/jamaneurol.2021.2418. JAMA Neurol. 2021. PMID: 34338714 Free PMC article. Clinical Trial.

2

Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial.

Ford AH, Flicker L, Thomas J, Norman P, Jamrozik K, Almeida OP. Ford AH, et al. J Clin Psychiatry. 2008 Aug;69(8):1203-9. doi: 10.4088/jcp.v69n0801. J Clin Psychiatry. 2008. PMID: 18557664 Clinical Trial.

3

The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life.

Ford AH, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida OP. Ford AH, et al. Trials. 2010 Jan 25;11:8. doi: 10.1186/1745-6215-11-8. Trials. 2010. PMID: 20096138 Free PMC article. Clinical Trial.

4

Vitamins B(12), B(6), and folic acid for cognition in older men.

Ford AH, Flicker L, Alfonso H, Thomas J, Clarnette R, Martins R, Almeida OP. Ford AH, et al. Neurology. 2010 Oct 26;75(17):1540-7. doi: 10.1212/WNL.0b013e3181f962c4. Epub 2010 Sep 22. Neurology. 2010. PMID: 20861451 Clinical Trial.

5

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study.

Ford AH, Flicker L, Hankey GJ, Norman P, van Bockxmeer FM, Almeida OP. Ford AH, et al. Mol Psychiatry. 2012 May;17(5):559-66. doi: 10.1038/mp.2011.18. Epub 2011 Mar 1. Mol Psychiatry. 2012. PMID: 21358708 Free PMC article.

6

Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia.

Ford AH, Flicker L, Alfonso H, Hankey GJ, Norman PE, van Bockxmeer FM, Almeida OP. Ford AH, et al. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):70-5. doi: 10.1136/jnnp.2011.242446. Epub 2011 Jul 11. J Neurol Neurosurg Psychiatry. 2012. PMID: 21746742

7

Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials.

Ford AH, Almeida OP. Ford AH, et al. J Alzheimers Dis. 2012;29(1):133-49. doi: 10.3233/JAD-2012-111739. J Alzheimers Dis. 2012. PMID: 22232016 Review.

8

Memory loss.

Flicker LA, Ford AH, Beer CD, Almeida OP. Flicker LA, et al. Among authors: ford ah. Med J Aust. 2012 Feb 6;196:114-7. doi: 10.5694/mja11.11399. Med J Aust. 2012. PMID: 22304604

9

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.

Ford AH, Garrido GJ, Beer C, Lautenschlager NT, Arnolda L, Flicker L, Almeida OP. Ford AH, et al. PLoS One. 2012;7(3):e33345. doi: 10.1371/journal.pone.0033345. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22413017 Free PMC article.

10

Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.

Hankey GJ, Ford AH, Yi Q, Eikelboom JW, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R, Almeida OP, van Bockxmeer FM; VITATOPS Trial Study Group. Hankey GJ, et al. Stroke. 2013 Aug;44(8):2232-9. doi: 10.1161/STROKEAHA.113.001886. Epub 2013 Jun 13. Stroke. 2013. PMID: 23765945 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,708 results

Search Page